US Patent Issued to Ellodi Pharmaceuticals on May 27 for "Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis" (Ohio Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,976, issued on May 27, was assigned to Ellodi Pharmaceuticals LP (Lawrenceville, N.J.).

"Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis" was invented by Michael A. Gosselin (Springboro, Ohio), Jin-Wang Lai (Springboro, Ohio) and Gopi M. Venkatesh (Vandalia, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflamm...